Trials / Not Yet Recruiting
Not Yet RecruitingNCT06850402
Evaluation of a Novel Optical Microscope With a Deep Depth of Field (DeepDOF) to Provide Histologic-quality Images on Cervical Biopsies and Loop Electrosurgical Excision Procedure (LEEP) Specimens at the Point-of-care
- Status
- Not Yet Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 400 (estimated)
- Sponsor
- M.D. Anderson Cancer Center · Academic / Other
- Sex
- Female
- Age
- 25 Years – 49 Years
- Healthy volunteers
- Not accepted
Summary
All patients will be enrolled in Mozambique and Brazil. They will provide informed consent to use their cervical biopsy and/or LEEP specimens for imaging with DeepDOF prior to sending for standard of care processing and interpretation.
Detailed description
Primary Objectives: 1. Evaluate the diagnostic performance of the DeepDOF digital histopathology platform compared with standard histopathology in cervical biopsies and/or LEEP specimens. 2. Compare performance characteristics between WLWH and HIV-negative women. Secondary Objectives: 1. Evaluate the ability of pathologists to provide a diagnostic evaluation of cervical biopsies and LEEP margins using digital DeepDOF images. 2. Develop DeepDOF algorithms for automated diagnostic evaluation of cervical biopsies and LEEP margins.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | DeepDOF Images | Women referred for consultation for cervical biopsy(ies) and/or LEEP will be recruited into the experimental group of the study. |
Timeline
- Start date
- 2026-06-01
- Primary completion
- 2027-09-01
- Completion
- 2028-09-01
- First posted
- 2025-02-27
- Last updated
- 2026-03-09
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT06850402. Inclusion in this directory is not an endorsement.